BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30062634)

  • 1. Chinese Medicine Yishen Jiangu Granules () on Aromatase Inhibitor-Associated Musculoskeletal Symptoms.
    Zhang X; Peng N; Yu MW; Zhang GL; Sun X; Yang GW; Li C; Yang L; Wang XM
    Chin J Integr Med; 2018 Nov; 24(11):867-872. PubMed ID: 30062634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: A randomized, controlled clinical trial.
    Peng N; Yu M; Yang G; Fu Q; Xu Y; Yu J; Liu Q; Li C; Xu W; Zhang Y; Ma C; Yang L; Yu R; Wang X
    Breast; 2018 Feb; 37():18-27. PubMed ID: 29059538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial.
    Rastelli AL; Taylor ME; Gao F; Armamento-Villareal R; Jamalabadi-Majidi S; Napoli N; Ellis MJ
    Breast Cancer Res Treat; 2011 Aug; 129(1):107-16. PubMed ID: 21691817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
    Crew KD; Capodice JL; Greenlee H; Brafman L; Fuentes D; Awad D; Yann Tsai W; Hershman DL
    J Clin Oncol; 2010 Mar; 28(7):1154-60. PubMed ID: 20100963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the traditional Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: a study protocol for a multicenter, randomized, controlled clinical trial.
    Peng N; Zhang Y; Ma C; Yu MW; Yang GW; Fu Q; Xu WR; Wang XM
    Trials; 2014 May; 15():171. PubMed ID: 24885324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.
    Greenlee H; Crew KD; Shao T; Kranwinkel G; Kalinsky K; Maurer M; Brafman L; Insel B; Tsai WY; Hershman DL
    Support Care Cancer; 2013 Apr; 21(4):1077-87. PubMed ID: 23111941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acupoint Thread Embedding Combined With Wenshen Bugu Decoction for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptom Among Postmenopausal Breast Cancer Patients: Study Protocol of a Randomized Controlled Trial.
    Zou X; Chen ZY; Yang YH; Qiao Y; He SJ; Li Q; Chen WL; Zhang XY; Li SY; Sha SY; Hu MH; Zhang XY; Yang MJ; Wang RP; Wu HG; Shi Y; Xue XH; Ji YJ
    Integr Cancer Ther; 2023; 22():15347354231188679. PubMed ID: 37565358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and treatment of aromatase inhibitor-associated bone loss by shugan jiangu recipe in postmenopausal women with breast cancer: a clinical study].
    Li YQ; Sun H; Xue D; Xu YC; Li ZD; Wang W; Li PP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1064-8. PubMed ID: 25335329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.
    Crew KD; Capodice JL; Greenlee H; Apollo A; Jacobson JS; Raptis G; Blozie K; Sierra A; Hershman DL
    J Cancer Surviv; 2007 Dec; 1(4):283-91. PubMed ID: 18648963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Campbell A; Heydarian R; Ochoa C; Dwivedi AK; Nahleh ZA
    Breast J; 2018 May; 24(3):260-268. PubMed ID: 29442401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms.
    Henry NL; Unger JM; Till C; Crew KD; Fisch MJ; Hershman DL
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34901744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Hershman DL; Unger JM; Greenlee H; Capodice JL; Lew DL; Darke AK; Kengla AT; Melnik MK; Jorgensen CW; Kreisle WH; Minasian LM; Fisch MJ; Henry NL; Crew KD
    JAMA; 2018 Jul; 320(2):167-176. PubMed ID: 29998338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer.
    Martinez JA; Wertheim BC; Roe DJ; Chalasani P; Cohen J; Baer L; Chow HS; Stopeck AT; Thompson PA
    Breast Cancer Res Treat; 2022 Feb; 192(1):113-122. PubMed ID: 35039952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study.
    Oh B; Kimble B; Costa DS; Davis E; McLean A; Orme K; Beith J
    Acupunct Med; 2013 Sep; 31(3):264-71. PubMed ID: 23722951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.
    Hershman DL; Unger JM; Crew KD; Awad D; Dakhil SR; Gralow J; Greenlee H; Lew DL; Minasian LM; Till C; Wade JL; Meyskens FL; Moinpour CM
    J Clin Oncol; 2015 Jun; 33(17):1910-7. PubMed ID: 25940724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.
    Lustberg MB; Orchard TS; Reinbolt R; Andridge R; Pan X; Belury M; Cole R; Logan A; Layman R; Ramaswamy B; Wesolowski R; Berger M; Patterson E; Loprinzi C; Shapiro CL; Yee L
    Breast Cancer Res Treat; 2018 Feb; 167(3):709-718. PubMed ID: 29101597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms.
    Bao T; Cai L; Snyder C; Betts K; Tarpinian K; Gould J; Jeter S; Medeiros M; Chumsri S; Bardia A; Tan M; Singh H; Tkaczuk KH; Stearns V
    Cancer; 2014 Feb; 120(3):381-9. PubMed ID: 24375332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment.
    Wang T; Huang YY; Liu XL; Molassiotis A; Yao LQ; Zheng SL; Tan JB; Huang HQ
    Support Care Cancer; 2022 Nov; 30(11):9279-9288. PubMed ID: 36065027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.
    Irwin ML; Cartmel B; Gross CP; Ercolano E; Li F; Yao X; Fiellin M; Capozza S; Rothbard M; Zhou Y; Harrigan M; Sanft T; Schmitz K; Neogi T; Hershman D; Ligibel J
    J Clin Oncol; 2015 Apr; 33(10):1104-11. PubMed ID: 25452437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Diuretics in Treatment of Aromatase Inhibitors Induced Musculoskeletal Symptoms in Women with Non Metastatic Breast Cancer.
    Alhanafy AM; Labeeb A; Khalil A
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3525-3531. PubMed ID: 30583679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.